WO2004018685A3 - Aktive fusionsproteine und verfahren zu ihrer herstellung - Google Patents

Aktive fusionsproteine und verfahren zu ihrer herstellung Download PDF

Info

Publication number
WO2004018685A3
WO2004018685A3 PCT/EP2003/009216 EP0309216W WO2004018685A3 WO 2004018685 A3 WO2004018685 A3 WO 2004018685A3 EP 0309216 W EP0309216 W EP 0309216W WO 2004018685 A3 WO2004018685 A3 WO 2004018685A3
Authority
WO
WIPO (PCT)
Prior art keywords
fusion proteins
production
active fusion
fragment
phage coat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/009216
Other languages
English (en)
French (fr)
Other versions
WO2004018685A2 (de
Inventor
Steffen Goletz
Martin Larsen
Peter Astrup Christensen
Kim Bak Jensen
Peter Kristensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nemod Immuntherapie AG
Original Assignee
Nemod Immuntherapie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nemod Immuntherapie AG filed Critical Nemod Immuntherapie AG
Priority to AU2003264075A priority Critical patent/AU2003264075A1/en
Publication of WO2004018685A2 publication Critical patent/WO2004018685A2/de
Publication of WO2004018685A3 publication Critical patent/WO2004018685A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Die Erfindung betrifft Fusionsproteine umfassend ein Expressionsprotein und ein Phagenhüllproteinfragment, wobei das Phagenhüllproteinfragment mindestens eine Dömane D1 oder ein funktionsanaloges Fragment dieser eines pIII eines filamentösen Bakteriophagen M13 ist.
PCT/EP2003/009216 2002-08-20 2003-08-20 Aktive fusionsproteine und verfahren zu ihrer herstellung Ceased WO2004018685A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003264075A AU2003264075A1 (en) 2002-08-20 2003-08-20 Active fusion proteins and method for the production thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2002138846 DE10238846A1 (de) 2002-08-20 2002-08-20 Aktive Fusionsproteine und Verfahren zu ihrer Herstellung
DE10238846.6 2002-08-20

Publications (2)

Publication Number Publication Date
WO2004018685A2 WO2004018685A2 (de) 2004-03-04
WO2004018685A3 true WO2004018685A3 (de) 2004-05-21

Family

ID=31197316

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/009216 Ceased WO2004018685A2 (de) 2002-08-20 2003-08-20 Aktive fusionsproteine und verfahren zu ihrer herstellung

Country Status (3)

Country Link
AU (1) AU2003264075A1 (de)
DE (1) DE10238846A1 (de)
WO (1) WO2004018685A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9493515B2 (en) * 2011-11-29 2016-11-15 Proclara Biosciences, Inc. Bacteriophage gene 3 protein compositions and use as amyloid binding agents
NZ706838A (en) * 2012-10-02 2017-06-30 Proclara Biosciences Inc Use of p3 of bacteriophage fusion proteins as amyloid binding agents
US9914770B2 (en) * 2013-04-30 2018-03-13 Intas Pharmaceuticals Ltd Cloning, expression and purification method for the preparation of ranibizumab
EP3003349B1 (de) 2013-05-28 2018-12-12 Proclara Biosciences, Inc. Polypeptide mit einer modifizierten bakteriophagen-g3p-aminosäuresequenz mit reduzierter immunogenität
KR20170085132A (ko) 2014-12-03 2017-07-21 프로클라라 바이오사이언시즈, 인크. 글리코실화 신호가 결핍된 변형된 박테리오파지 ｇ3ｐ 아미노산 서열을 포함하는 폴리펩티드

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022393A1 (en) * 1995-01-17 1996-07-25 Bioinvent International Ab Improved method of selecting specific bacteriophages
US5750373A (en) * 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
US5837500A (en) * 1988-09-02 1998-11-17 Dyax, Corp. Directed evolution of novel binding proteins
JPH11310596A (ja) * 1998-04-28 1999-11-09 Seibutsu Bunshi Kogaku Kenkyusho:Kk 骨髄間質細胞抗原結合蛋白質

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837500A (en) * 1988-09-02 1998-11-17 Dyax, Corp. Directed evolution of novel binding proteins
US20030219722A1 (en) * 1988-09-02 2003-11-27 Ladner Robert Charles Fusion proteins, modified filamentous bacteriophage, and populations or libraries of same
US5750373A (en) * 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
US5821047A (en) * 1990-12-03 1998-10-13 Genentech, Inc. Monovalent phage display
US6040136A (en) * 1990-12-03 2000-03-21 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
WO1996022393A1 (en) * 1995-01-17 1996-07-25 Bioinvent International Ab Improved method of selecting specific bacteriophages
JPH11310596A (ja) * 1998-04-28 1999-11-09 Seibutsu Bunshi Kogaku Kenkyusho:Kk 骨髄間質細胞抗原結合蛋白質

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHANGSHOU GAO ET AL: "Making artificial antibodies: A format for phage display of combinatorial heterodimeric arrays", PROC. NATL. ACAD. SCI., vol. 96, May 1999 (1999-05-01), pages 6025 - 6030, XP002269692 *
DENG LIH-WEN ET AL: "Delineating the site of interaction on the pIII protein of filamentous bacteriophage fd with the F-pilus of Escherichia coli.", JOURNAL OF MOLECULAR BIOLOGY. ENGLAND 7 JUN 2002, vol. 319, no. 3, 7 June 2002 (2002-06-07), pages 603 - 614, XP002269693, ISSN: 0022-2836 *
IGOR FISCH ET AL: "A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage", PROC. NATL. ACAD. SCI., vol. 93, July 1996 (1996-07-01), pages 7761 - 7766, XP002269691 *
LIH-WEN DENG ET AL: "Interaction of the Globular Domains of pIII Protein of Filamentous Bacteriophage fd with the F-Pilus of Escherichia coli", VIROLOGY, vol. 253, 1999, pages 271 - 277, XP002269690 *
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 02 29 February 2000 (2000-02-29) *

Also Published As

Publication number Publication date
WO2004018685A2 (de) 2004-03-04
AU2003264075A1 (en) 2004-03-11
DE10238846A1 (de) 2004-03-04
AU2003264075A8 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
AU2001272646A1 (en) System, method and article of manufacture for software-designed internet reconfigurable hardware
DE60202648D1 (de) Verfahren zur Herstellung von kuppelförmigen Gegenständen mit grossem Durchmesser
MXPA03003545A (es) Metodo para elaborar articulos revestidos, y los articulos revestidos a partir del mismo.
DE60301350D1 (de) Verfahren zur herstellung von 7-substituierten -3-chinolin und 3-chinol-4-on carbonitrile
ID22821A (id) Turunan sulfonamida, proses pembuatannya dan penggunaannya sebagai obat
NO330897B1 (no) Fremgangsmate for fremstilling av et protein, der proteinet er et fragment av et protein som er et primaert translatertprodukt av et malgen som enten er C- eller N-terminalen idet primaere translaterte produkt fra et malgen, og derfragmentet har en biologisk funksjon
WO2002060920A3 (en) Prion isomers, methods of making, methods of using, and compositions and products comprising prion isomers
AU2003211625A1 (en) Method of modifying protein properties
WO2004013160A3 (en) Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
NO20026007L (no) Rörsammenstilling av kompositt samt fremgangsmåte for fremstilling av denne
WO2004001418A3 (de) Verfahren zum nachweis und zur entfernung von endotoxin
FR2808523B1 (fr) Procede de production conjointe ou non de monoakylaromatiques, dialkyl aromatiques et trialkyl aromatiques
EP1668125A4 (de) Modifizierte enzyme, verfahren zur herstellung modifizierter enzyme und verwendungen davon
WO2004018685A3 (de) Aktive fusionsproteine und verfahren zu ihrer herstellung
WO2001038566A3 (en) Screening method for candidate drugs
AUPQ712000A0 (en) Antigenic peptide fragments of VapA protein, and uses thereof
WO2002055560A3 (en) Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
WO2002034915A3 (en) Preferred segments of neural thread protein and methods of using the same
WO2002073373A3 (en) Ensemble-based strategy for the design of protein pharmaceuticals
AU2003297269A1 (en) Bacteriophage having modified holin and uses thereof
DE60114567D1 (de) Selektive acylierung von a82846-glycopeptid-analoge
NO20010254L (no) Komposittprodukt og fremgangsmåte til fremstilling av dette
BR0310126B1 (pt) mÉtodo de conservaÇço de produto de madeira, e produto de madeira tendo propriedades inseticidas/acaricidas.
AU2002365084A1 (en) Method and reagent for the detection of proteins and peptides
EP0780472A3 (de) Stress Proteine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP